Archive
Proactive news snapshot: Jersey Oil & Gas, Flying Brands, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 11 of 15
Allergy Therapeutics set to begin phase II trial of PQ Grass hay fever treatment “imminently”
The allergy vaccine specialist has received regulatory approval to start the phase II trial
Archive
Proactive news snapshot: ANGLE, Jersey Oil & Gas, Mosman Oil And Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Zibao Metals shines as it confirms revenue and profit growth this year
Some of the main news-driven risers and fallers at 3.35pm...
Allergy Therapeutics strengthens clinical research team with senior appointments
Pieter-Jan de Kam joins as clinical director, while Simon Piggott will become head of clinical science
FTSE 100 closes almost 36pts up as traders buy back in
The blue chip index closed out almost 36 points higher at 7,413
Archive
Proactive news snapshot: Kin Group, Allergy Therapeutics, 88 Energy ...
A glance at some of the stories on the Proactive newswire today
Investments and investor services
IG Group: up the polls!
Companies featured: HaloSource, Ascent Resources, Inspirit Energy, Clear Leisure, Safestyle, Nyota MInerals, IG Group, Polemos, Ortac Resources
Allergy Therapeutics sales soar as market share in Europe rises
Allergy continued to gain market share in Europe with its hay fever vaccines Pollinex Quattro and Pollinex
Allergy Therapeutics revenues rise as hay fever portfolio cleans up
Finncap's revenue forecasts were upgraded by 6% and 7% to £72.2mln and £79.5mln for the full year 2017 and 2018 respectively.
Archive
Proactive news round-up: Gfinity, MySQUAR, Sound Energy…
A glance at some of the stories on the Proactive newswire today
Microgen surges on back of "exceptional level of demand" for its Aptitude software
Microgen reckons full-year performance will be significantly ahead of expectations
Allergy Therapeutics publishes pre-clinical data on malaria and flu vaccines
The studies were carried out through Allergy’s Bencard Adjuvant Systems division.
FTSE 100 pares losses despite sharp fall in US equities
Lancashire Holdings rose in sympathy with Novae as the Lloyd's specialist insurer sold out to AXIS Holdings
Archive
Proactive News round-up: Obtala, Sabien Technology, Sound Energy ...
A glance at some of the stories on the Proactive newswire today
Long wait to supply Airbus is over for Hardide
Some of the largest risers and fallers in London at 3.15pm
Allergy Therapeutics confident of further growth
Its European markets were largely flat but the company still managed to achieve top-line growth of 18% on a constant currency basis
Archive
Have a break, have a Brexit
Article 50 will be triggered on Wednesday but there is still a lot of horse trading to be done over the coming months before Britain's departure from the EU is settled